Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-12-29
2009-06-09
Schnizer, Richard (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S023500, C530S350000, C424S450000, C424S207100, C424S233100, C435S320100, C435S459000
Reexamination Certificate
active
07544670
ABSTRACT:
The present invention provides methods and compositions useful in localized transfer of genetic material or proteins. Moreover, the present invention provides methods and compositions for improving and/or controlling wound healing by applying a wound care device comprising HoxD3 and/or HoxA3 and/or HoxB3. In addition, the present invention provides methods and compositions for improved wound healing in subjects having impaired healing capabilities, such as diabetic and aged subjects.
REFERENCES:
patent: 4708861 (1987-11-01), Popescu et al.
patent: 5558861 (1996-09-01), Yamanaka et al.
patent: 6143037 (2000-11-01), Goldstein et al.
patent: 2003/0206944 (2003-11-01), Cohen et al.
patent: 1074617 (2001-02-01), None
patent: WO-01/90127 (2001-11-01), None
Boudreau et al (J. Cell Biol. 139(1): 257-264, 1997).
Hansen et al (Am. J. Pathol. 163(6): 2421-2431, 2003).
Chen et al (J. Cerebral Blood Flow and Metabolism 24(1: 1280-1287, 2004).
Boudreau, N. et al. (Dec. 2002). “Homeobox Genes and Angiogenesis: Regulation of Extracellular Matrix Remodeling,” 42nd Annual Meeting of The American Society for Cell Biology, San Fracisco, CA, Dec. 14-18, 2002, Abstract for Presentation No. 1596, 1 page.
Boudreau, N. et al. (2004). “The Homeobox Transcription Factor Hox D3 Promotes Integrin α5β1Expression and Function During Angiogenesis,”The Journal of Biological Chemistry279(6):4862-4868.
Chandler, L. A. et al. (2000). “Matrix-Enabled Gene Transfer for Cutaneous Wound Repair,”Wound Repair and Regeneration8(6):473-479.
Duboule, D. (2000). “A Hox by Any Other Name,”Nature403:608-610.
Eming, S. A. et al. (2002). “Treatment of Chronic Wounds: State of the Art and Future Concepts,”Cells Tissues Organs172:105-117.
Eriksson, E. (2000). “Gene Transfer in Wound Healing,”Advances in Skin&Wound Care13(2 Suppl):20-22. (Abstract only obtained from PubMed, PMID:11074999, 1 page).
GenBank Accession No. X16667, located at <http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=32379> visited on Sep. 25, 2008, 2 page.
Greer, J. M. et al. (2000). “Maintenance of Functional Equivalence During Paralogous Hox Gene Evolution,”Nature403:661-665.
Hansen, S. L. et al. (Dec. 2002). “HoxA3 Promotes Endothelial Cell Migration and Angiogenesis,” 42nd Annual Meeting of The American Society for Cell Biology, San Francisco, CA, Dec. 14-18, 2002, Abstract for Presentation No. 1949, Poster Board No. B359, 1 page.
International Search Report and Written Opinion mailed Oct. 19, 2005, for PCT Application No. PCT/US204/42243 filed Dec. 15, 2004, 8 pages.
International Search Report mailed Jul. 11, 2003, for PCT Application No. PCT/US02/19020 filed Jun. 14, 2002, 6 pages.
Mace, K. A. et al. (2005). “HoxA3 Induces Cell Migration in Endothelial and Epithelial Cells Promoting Angiogenesis and Wound Repair,”Journal of Cell Sciences118:2567-2577.
Myers, C. et al. (2000). “Homeobox B3 Promotes Capillary Morphogenesis and Angiogenesis,”The Journal of Cell Biology148(2):343-351.
Sabolinkski, M. L. et al. (1996). “Cultured Skin as ‘Smart Material’ for Healing Wounds: Experience in Venous Ulcers,”Biomaterials17:311-320.
Stadelmann, W. K. et al. (1998). “Physiology and Healing Dynamics of Chronic Cutaneous Wounds,”The American Journal of Surgery176(Suppl 2A):26S-38S.
Strausberg, R. L. et al. (2002). “Generation and Initial Analysis of More than 15,000 Full-Length Human and Mouse cDNA Sequences,”Proceedings of the National Academy of Sciences of the United States of America99(26):16899-16903.
Theopold, C. et al. (2004). “Gene Therapy in the Treatment of Lower Extremity Wounds,”Lower Extremity Wounds3(2):69-79.
Uyeno, L. A. (2001). “Hox D3 Expression in Normal and Impaired Wound Healing,”Journal of Surgical Research100:46-56.
Yao, F. (2000). “Gene Therapy in Wound Repair and Regeneration,”Wound Repair and Regeneration8:443-451.
Boudreau Nancy
Myers Cornelia
Young David M.
Morrison & Foerster / LLP
Schnizer Richard
The Regents of the University of California
LandOfFree
HoxD3, HoxA3 and HoxB3 compositions and methods for improved... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HoxD3, HoxA3 and HoxB3 compositions and methods for improved..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HoxD3, HoxA3 and HoxB3 compositions and methods for improved... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4146333